Status:
COMPLETED
Danish Aspirin Resistance Trial - Pilot Study
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Danish Research Agency
Conditions:
Drug Resistance
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Despite treatment with aspirin a large number of patients suffer a myocardial infarction. It has been speculated that these patients might be "resistant" to aspirin, and studies have indicated that th...
Detailed Description
Platelets play a major role in arterial thrombus formation - the cause of cardiovascular death, acute myocardial infarction and ischemic stroke and the number one killer in the Western World. Binding ...
Eligibility Criteria
Inclusion
- ischemic heart disease verified with a coronary angiogram
- treatment with 75 mg aspirin once daily
Exclusion
- ischemic vascular event within the previous 12 months
- percutaneous coronary intervention or coronary artery by-pass grafting within the previous 12 months
- treatment with NSAID, clopidogrel, ticlopidine, dipyridamole, warfarin or any other drug affecting platelet aggregation
- platelet count \< 120 x 10\^9/l
- not able to give informed consent
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00389129
Start Date
November 1 2006
End Date
March 1 2007
Last Update
December 12 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology, Skejby Sygehus, Aarhus University Hospital
Aarhus, Denmark, 8200